header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

General Orthopaedics

AVOIDING PATELLAR CLUNK AND CREPITUS: RUNNING SILENT

Current Concepts in Joint Replacement (CCJR) Winter 2017 Meeting, Orlando, FL, USA, December 2017.



Abstract

Patellofemoral complaints are the common and nagging problem after total knee arthroplasty. Crepitus occurs in 5% to over 20% of knee arthroplasty procedures depending on the type of implant chosen. It is caused by periarticular scar formation with microscopic and gross findings indicating inflammatory fibrous hyperplasia.

Crepitus if often asymptomatic and not painful, but in some cases can cause pain. Patella “Clunk Syndrome” is less common and represents when the peripatella scarring is abundant and forms a nodule which impinges and “catches” on the implant's intercondylar notch. Patella Clunk was more common with early PS designs due to short trochlear grooves with sharp transition into the intercondylar notch. Clunks are very infrequent with modern PS implants. This syndrome has been reported in CR implants as well.

Thorough debridement of the synovium and scarring at the time of arthroplasty is thought to reduce the occurrence of crepitus and clunks. Larger patella with better coverage of the cut bone may also be helpful.

The diagnosis can be made on history and physical exam. X-rays are also helpful to assess patella tracking. MRI or ultrasound can be used to identify and confirm the diagnosis, but this is not mandatory.

Painful crepitus and clunk syndrome that fail conservative management of NSAIDS and physical therapy may require surgery. Both crepitus and clunk can be treated with arthroscopic removal of the peripatella scar. Patella maltracking should also be assessed and treated. While recurrence may occur, it is uncommon.